Frantz Viral Therapeutics, LLC
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
- Conditions
- Anal High-grade Squamous Intraepithelial LesionAnal HSILAnal HPV InfectionAIN
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Frantz Viral Therapeutics, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT06206564
- Locations
- 🇺🇸
Anal Dysplasia Clinic MidWest, Chicago, Illinois, United States
🇺🇸Laser Surgery Care, New York, New York, United States
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
- Conditions
- HPV InfectionVIN 3 of Usual TypeVIN Grade 2VIN Grade 3High Grade Intraepithelial NeoplasiaVulvar DiseasesVulvar HSILVIN 2 of Usual TypeVin IIVin III
- Interventions
- Drug: Placebo ointment
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Frantz Viral Therapeutics, LLC
- Target Recruit Count
- 27
- Registration Number
- NCT06075264
- Locations
- 🇺🇸
Florida Gynecologic Oncology, Fort Myers, Florida, United States
🇺🇸Ascension St. Vincent, Indianapolis, Indiana, United States
🇺🇸Cleveland Clinic Fairview Hospital, Cleveland, Ohio, United States
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
- Conditions
- Anal DysplasiaAnal High Grade Squamous Intraepithelial LesionHPV InfectionAnal Precancerous ConditionHPV DiseaseAIN 2/3
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-09-27
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Frantz Viral Therapeutics, LLC
- Target Recruit Count
- 17
- Registration Number
- NCT05555862
- Locations
- 🇺🇸
Anal Dysplasia Clinic MidWest, Chicago, Illinois, United States
🇺🇸Laser Surgery Care, New York, New York, United States
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
- Conditions
- Cervical DysplasiaHPV Related DiseaseHPV InfectionPre-Cancerous DysplasiaCIN 2/3
- Interventions
- Drug: Placebo vaginal insert
- First Posted Date
- 2019-09-23
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Frantz Viral Therapeutics, LLC
- Target Recruit Count
- 78
- Registration Number
- NCT04098744
- Locations
- 🇺🇸
Florida Gynecologic Oncology, Fort Myers, Florida, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Cleveland Clinic Fairview Hospital, Cleveland, Ohio, United States